Orthofix Medical Inc.

Orthofix Medical Inc. (NASDAQ: OFIX) is a global medical technology company headquartered in Lewisville, Texas and operating through its website at www.orthofix.com. The company designs, manufactures, and distributes medical devices and biologics focused on musculoskeletal pathologies, offering comprehensive solutions for spinal conditions and limb reconstruction procedures.

The company operates through two primary reporting segments. The Global Spine segment, representing 84 percent of net sales, provides implantable medical devices, biologics, enabling technologies, and regenerative solutions for spinal conditions. This segment encompasses bone growth therapies including pulsed electromagnetic field and low-intensity pulsed ultrasound stimulation devices, spinal implants and fixation systems covering the entire spinal column from cervical to sacral regions, the 7D FLASH Navigation System for image-guided spine and cranial surgery, and a comprehensive biologics portfolio featuring demineralized bone matrices, cellular allografts, and synthetic bone void fillers. The Global Limb Reconstruction segment, representing 16 percent of net sales, specializes in external and internal fixation devices for deformity correction, limb lengthening, complex fracture management, and limb preservation, including the TrueLok external fixation system, Fitbone intramedullary limb-lengthening system, and the OrthoNext digital planning platform.

Orthofix was founded in Verona, Italy in 1980 and incorporated in Curaçao before relocating its jurisdiction of organization to Delaware in 2018. In January 2023, the company completed a merger of equals with SeaSpine Holdings Corporation, significantly expanding its spinal implant and enabling technology portfolio. The combined entity continues to trade on NASDAQ under the symbol OFIX.

The company distributes its products globally through a network of direct sales representatives and independent distributors to hospitals, ambulatory surgery centers, and outpatient facilities. Orthofix maintains manufacturing and research facilities across multiple locations and serves healthcare providers and patients worldwide. The company's product portfolio includes numerous proprietary brands and technologies, with particular strength in bone growth stimulation, spinal fixation systems, and limb reconstruction solutions supported by clinical evidence and peer-reviewed research.